Based on 20 years of work at the University of Kentucky, and $11M in grants to bring it to commercial readiness, Phytogenesis is a fundamentally different solution for protecting the world’s crops from fast-evolving pathogens. 

For ag investors, the biocontrol market is structurally problematic, because a product that works in potatoes doesn’t then work for corn, or fresh produce. Each crop needs its own solution, limiting upside. 

Phytogenesis’ product, PreviSAR, is a single biobased solution for all crops. It primes an innate defense pathway native to all plants, called Systemic Acquired Resistance. It only needs to be applied once per season, and when applied to any leaf, it spreads through the whole plant. The result is a very meaningful savings to the farmer. PreviSAR can also be combined with existing crop protection products, be they bio or chemical. 

Over 25 field trials in row and specialty crops have them preparing to work with large growers, first in South America which has the world’s fastest regulatory pathway for biologicals, followed quickly by the USA. 
PreviSAR has conceptual similarities to two products that ag investors will know well – Regalia and Phytalix – but it is distinctly unique; our scientific founders discovered an upstream way to regulate Systemic Acquired Resistance. Ag investors familiar with the biocontrol space will want to absorb this update on the scientific field.

PreviSAR can even be applied prior to harvest, and it keeps working post-harvest, protecting the crop from infection. Less food waste and no more moldy strawberries